Institute Partner Program
Give your survivors a shared, portable survivorship home.
Cancer centers, AYA programs, self-insured employers, and research consortia partner with the Institute to bring NCCN, ASCO, and COG-LTFU aligned survivorship care to their populations.
The Category
What real survivorship care looks like — and what it doesn't.
| Capability | Life Spark Institute | PCP alone | Oncology f/u alone | Generic patient portal |
|---|---|---|---|---|
| Structured survivorship care plan (dx, tx summary, late-effects) | ✓ | — | ~ | — |
| Cardio-oncology surveillance (echo, ApoB, BP, A1c) | ✓ | — | ~ | — |
| Second-cancer & recurrence screening calendar | ✓ | — | ~ | — |
| Cognition, sleep, distress & sexual-health PROs | ✓ | ~ | — | — |
| AYA transition-of-care planning (peds → adult) | ✓ | — | — | — |
| Financial-toxicity & caregiver support screens | ✓ | — | — | — |
| Portable FHIR record you can hand to any clinician | ✓ | — | — | ~ |
| Consent-scoped data sharing & PHI access audit trail | ✓ | — | — | — |
| Aligned to NCCN, ASCO & COG survivorship guidance | ✓ | — | ~ | ~ |
| Clinician cohort dashboard with overdue-screen flags | ✓ | — | — | — |
Institute Impact Model
What a 1,000-survivor cohort looks like on the Institute.
Modeled from our consented pilot cohort. Individual results vary; provided for partner planning and IRB discussion, not as a guarantee of clinical outcomes.
See the KPI framework →| Measure | Mo. 3 | Mo. 6 | Mo. 12 |
|---|---|---|---|
| Survivorship charts completed | 62% | 84% | 94% |
| On-time cardio-oncology surveillance | +18% | +29% | +38% |
| Care-plan completeness within 90 days | +41% | +52% | +58% |
| AYA transition plans on file | 48% | 71% | 83% |
| Median NCCN Distress drop | −0.6 | −1.4 | −1.9 |
Illustrative cohort model. Not a guarantee of clinical outcomes. Full methodology available to partners on request.
20 min
Clinician time saved / visit
83%
AYA retention at 12 mo
72
Survivor NPS
The Platform
A survivorship platform, not another portal.
Every survivor and every partner works out of one integrated stack — chart, PROs, care-team workspace, transition toolkit, FHIR, and a full audit trail. Consent-first by design.
Survivorship Chart
Purpose-built longitudinal chart with treatment summary, late-effects risk profile, and a live surveillance calendar per primary.
PRO Trackers
PROMIS, FACT-Cog, NCCN Distress, sleep, sexual health, and financial toxicity — trended over time and shareable with your care team.
Care-Team Workspace
Invite oncology, PCP, and specialists into a scoped, audited view. Overdue-surveillance flags routed automatically. Locked until HIPAA readiness.
AYA Transition Toolkit
Structured adolescent-to-adult transition plans, checklist-driven hand-offs, and a portable record that survives the move to adult care.
FHIR In / Out (planned)
Bidirectional FHIR with cancer centers and PCP EMRs. Off by default; enabled per consent once HIPAA readiness ships.
Audit Trail & Consent
Every view, export, and share is logged. Survivors see who accessed their chart and can revoke access at any time.
Partner Onboarding Path
From first conversation to live cohort in under 8 weeks.
Phase 1 — Discovery (Weeks 0–2)
Fit conversation, population profile, and a walkthrough of the Institute chart, protocols, and consent model.
Phase 2 — Configuration (Weeks 2–4)
Co-branding, cohort scoping, NCCN/ASCO/COG protocol library selection, and consent-flow customization for your survivors.
Phase 3 — Clinician Onboarding (Weeks 4–6)
Care-team workspace training, PRO review workflow, overdue-surveillance escalation, and audit-trail orientation. Locked until HIPAA readiness.
Phase 4 — Survivor Launch (Weeks 6–8)
Invitation flow, patient-education library, mentor/peer connections, and go-live support with your survivor community.
Phase 5 — Operate & Iterate (Ongoing)
Monthly QA, quarterly outcomes review, annual protocol refresh, and cohort-level KPI reporting against the Institute standard.
Institute Partner Sites
A survivorship network taking shape across the country.
Cancer centers, AYA programs, and community survivorship clinics adopting the Institute chart and protocols. Illustrative; individual partner status confirmed under NDA.
- Austin, TXFlagship
- Houston, TXActive
- Phoenix, AZActive
- Nashville, TNActive
- Charlotte, NCActive
- Miami, FLActive
- Atlanta, GAActive
- Denver, COOnboarding
- Chicago, ILOnboarding
- NYC MetroOnboarding
- Boston, MAInterested
- Seattle, WAInterested
- LA, CAInterested
- SF Bay, CAInterested
- MinneapolisInterested
- PhiladelphiaInterested
Institute Partner Program
Bring the Institute to your survivor population.
Cancer centers, AYA programs, employer benefits teams, and research consortia partner with us to give survivors a shared, portable, guideline-aligned home for their care.
- Co-branded Institute deployment for your cohort
- NCCN / ASCO / COG-LTFU-aligned protocol library
- AYA transition-of-care workflows built in
- Cohort-level surveillance-completion reporting
- Consented, de-identified registry for research
- Onboarding, training, and quarterly outcomes review
Dispute Resolution (Franchise Agreement, Section 13 — archived)
Good-faith discussion first. Then mediation. Then binding arbitration.
Summary of the dispute-resolution cascade that appears in the archived Life Spark Franchise Agreement and every ancillary agreement. Preserved here for reference while the franchise program is paused. Full text controls in the event of any conflict with this summary. No court. No jury.
Step 1 · Good-Faith Negotiation
Before initiating any formal proceeding, the parties shall attempt in good faith to resolve any dispute by direct discussion between senior representatives for at least thirty (30) days from written notice of dispute.
Step 2 · Mediation
If unresolved, the parties shall participate in non-binding mediation administered by JAMS under its then-current mediation rules, in Wilmington, Delaware, for at least one (1) full-day session, with mediator fees split equally.
Step 3 · Binding Arbitration
Any dispute not resolved under Steps 1 and 2 shall be finally resolved by binding arbitration administered by JAMS under its Comprehensive Arbitration Rules and Procedures, before a single arbitrator, seated in Wilmington, Delaware, conducted in English. The arbitrator's award shall be final and enforceable in any court of competent jurisdiction solely for confirmation or enforcement.
No Court. No Jury. No Class Actions.
EACH PARTY IRREVOCABLY WAIVES ANY RIGHT TO LITIGATE IN COURT AND ANY RIGHT TO A TRIAL BY JURY. No claim shall be heard in court or before a jury, with the sole exception of (i) actions to confirm, vacate, or enforce an arbitral award, and (ii) applications for emergency injunctive relief in aid of arbitration, which the parties consent to bring exclusively before the state or federal courts located in Wilmington, Delaware. All disputes shall be resolved on an individual basis; class, collective, and representative actions are waived to the maximum extent permitted by law.
Confidentiality of Proceedings
The existence, content, and outcome of any negotiation, mediation, or arbitration shall be confidential, subject only to disclosures required by law or for award enforcement.
This summary is app-owned editable content maintained by Life Spark; it is not legal advice and does not itself create a contract. Any party considering the archived franchise agreement should review the full document with its own counsel.